2023
DOI: 10.1016/j.jinorgbio.2022.112100
|View full text |Cite
|
Sign up to set email alerts
|

Exploring heterometallic bridged Pt(II)-Zn(II) complexes as potential antitumor agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
19
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(23 citation statements)
references
References 48 publications
3
19
1
Order By: Relevance
“…The elemental analyses, UV–Vis, IR, 1 H, 13 C NMR and ESI‐MS spectroscopy were used for characterization of the synthesized C1a–C4a complexes (Supporting Information, see Figures S1 and S2). The synthetic pathway for the preparation of complexes is the same as published before for heterometallic complexes that contain unsubstituted 2,2′;6′,2″‐terpyridine inert ligand 3 …”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…The elemental analyses, UV–Vis, IR, 1 H, 13 C NMR and ESI‐MS spectroscopy were used for characterization of the synthesized C1a–C4a complexes (Supporting Information, see Figures S1 and S2). The synthetic pathway for the preparation of complexes is the same as published before for heterometallic complexes that contain unsubstituted 2,2′;6′,2″‐terpyridine inert ligand 3 …”
Section: Resultsmentioning
confidence: 99%
“…The complexes C1a–C4a were synthesized following already published procedures. 3 . Generally, to solutions of cis ‐[PtCl 2 (NH 3 ) 2 ] or trans ‐[PtCl 2 (NH 3 ) 2 ] (0.036 g, 0.12 mmol, 20 ml H 2 O) a less than one equivalent of AgClO 4 (0.0249 g, 0.12 mmol) was added dropwise.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations